• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$71.10 -$0.50 (-0.70%)

REAL-TIME: Last trade at

Sigma-Aldrich Corp

NASDAQ:SIAL

Jump to this page for:

Related Resources

Sigma-Aldrich Extends Credit Line

5/17/2012 by Zacks Equity Research Analyst Blog

Sigma-Aldrich Extends Credit Line - Analyst Blog

5/17/2012 by Zacks Investment Research

Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences

5/17/2012 by StockWatch

Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences

5/17/2012 by PR Newswire

Sigma-Aldrich gets new $600 million credit deal

5/17/2012 by St. Louis Post-Dispatch - St Louis MO

Sigma-Aldrich Corporation Announces New Credit Facility

5/16/2012 by PR Newswire

Sigma-Aldrich Corporation Announces New Credit Facility

5/16/2012 by StockWatch

Neutral on Sigma-Aldrich - Analyst Blog

5/16/2012 by Zacks Investment Research

Neutral on Sigma-Aldrich

5/16/2012 by Zacks Equity Research Analyst Blog

Global Cell-Based Assays Industry

5/16/2012 by PR Newswire

Global Laboratory Chemical Reagents Industry

5/16/2012 by PR Newswire

Sigma-Aldrich has a conference call hosted by JP Morgan

5/8/2012 by Theflyonthewall.com

Sigma-Aldrich Corp (SIAL) Declares $0.20 Quarterly Dividend; 1.1% Yield

5/3/2012 by StreetInsider.com

Sigma-Aldrich Declares Quarterly Dividend

5/2/2012 by Genetic Engineering News

Sigma(R) Life Science Introduces Kit For Integrating Transgenes Into The Rosa26 Rat Locus

4/27/2012 by Biocompare

Sigma® Life Science Introduces Kit for Integrating Transgenes into the Rosa26 Rat Locus

4/26/2012 by PR Newswire

Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences

4/25/2012 by StockWatch

Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences

4/25/2012 by PR Newswire

First quarter profits down at Sigma-Aldrich

4/24/2012 by St. Louis Post-Dispatch - St Louis MO

Sigma-Aldrich's CEO Discusses Q1 2012 Results - Earnings Call Transcript

4/24/2012 by Seeking Alpha

Sigma-Alrich Profit Declines, But In Line With Street - Update

4/24/2012 by RTTNews

Sigma-Aldrich’s profit falls 1.7 percent in Q1

4/24/2012 by St. Louis Business Journal - St. Louis MO

Sigma-Aldrich raises 2012 free cash flow outlook to $425M from $400M

4/24/2012 by Theflyonthewall.com

Sigma-aldrich Corp (SIAL) Reports In-Line Q1 EPS of 99c

4/24/2012 by StreetInsider.com

Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.

4/24/2012 by PR Newswire

SAGE® Labs Creates The First Tissue-Specific Gene Deletion In Rats

4/22/2012 by Biocompare

University of Illinois at Urbana-Champaign Announces Licensing Agreement with Sigma-Aldrich to Provide Membrane Scaffold Proteins for Nanodisc Technology to the Research Community

4/20/2012 by PharmiWeb.com - UK

University of Illinois at Urbana-Champaign Announces Licensing Agreement with Sigma-Aldrich to Provide Membrane Scaffold Proteins for Nanodisc Technology to the Research Community

4/19/2012 by Business Wire

SAGE(R) Labs Creates The First Tissue-Specific Gene Deletion In Rats

4/19/2012 by Biocompare

SAGE® Labs Creates the First Tissue-Specific Gene Deletion in Rats

4/19/2012 by PR Newswire

Sigma-Aldrich Intros CHOZN System - Analyst Blog

4/16/2012 by NASDAQ

Sigma-Aldrich Intros CHOZN System - Analyst Blog

4/16/2012 by Zacks Investment Research

Sigma-Aldrich Intros CHOZN System

4/16/2012 by Zacks Equity Research Analyst Blog

Global Gene Amplification Technologies Industry

4/16/2012 by PR Newswire

Western Lithium Demonstrates High Performance Results From Rechargeable Lithium Ion Battery Testing at Argonne National Laboratory and Provides Operations Update

4/16/2012 by StockWatch

Western Lithium Demonstrates High Performance Results From Rechargeable Lithium Ion Battery Testing at Argonne National Laboratory and Provides Operations Update

4/16/2012 by Marketwire

Retaining Sigma-Aldrich at Neutral - Analyst Blog

4/13/2012 by Zacks Investment Research

Retaining Sigma-Aldrich at Neutral

4/13/2012 by Zacks Equity Research Analyst Blog

Sigma-Aldrich Corporation Announces Q1-2012 Conference Call

4/12/2012 by GlobeNewswire

SAFC Launches CHOZN® Platform System to Accelerate Recombinant Protein Drug Development

4/11/2012 by PR Newswire
See More Articles...